MedPath

Essen Technology (Beijing) Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization

Not Applicable
Conditions
Ischemic Heart Disease
Myocardial Ischemia
Coronary Artery Lesions,Primary
Coronary Disease
Acute Coronary Syndrome
Furcation Lesion of Coronary Artery
First Posted Date
2012-09-07
Last Posted Date
2013-02-21
Lead Sponsor
Essen Technology (Beijing) Co., Ltd.
Target Recruit Count
2790
Registration Number
NCT01681381
Locations
🇨🇳

The General Hospital of Shenyang Military Region, Shenyang, Liaoning, China

News

No news found
© Copyright 2025. All Rights Reserved by MedPath